Liver metastasis from colorectal cancer: pathogenetic development, immune landscape of the tumour microenvironment and therapeutic approaches

J Exp Clin Cancer Res. 2023 Jul 22;42(1):177. doi: 10.1186/s13046-023-02729-7.

Abstract

Colorectal cancer liver metastasis (CRLM) is one of the leading causes of death among patients with colorectal cancer (CRC). Although immunotherapy has demonstrated encouraging outcomes in CRC, its benefits are minimal in CRLM. The complex immune landscape of the hepatic tumour microenvironment is essential for the development of a premetastatic niche and for the colonisation and metastasis of CRC cells; thus, an in-depth understanding of these mechanisms can provide effective immunotherapeutic targets for CRLM. This review summarises recent studies on the immune landscape of the tumour microenvironment of CRLM and highlights therapeutic prospects for targeting the suppressive immune microenvironment of CRLM.

Keywords: Colorectal cancer liver metastasis; Immune landscape; Immunotherapy; Premetastatic niche; Tumour microenvironment.

Publication types

  • Review

MeSH terms

  • Colorectal Neoplasms* / therapy
  • Humans
  • Immunotherapy
  • Liver Neoplasms* / therapy
  • Tumor Microenvironment